This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Dec 20;342(6165):1432-3.

doi: 10.1126/science.342.6165.1432.

Breakthrough of the year 2013. Cancer immunotherapy

Jennifer Couzin-Frankel

PMID: 24357284
DOI: 10.1126/science.342.6165.1432

Breakthrough of the year 2013. Cancer immunotherapy

Jennifer Couzin-Frankel. Science. 2013.

. 2013 Dec 20;342(6165):1432-3.

doi: 10.1126/science.342.6165.1432.

Author

Jennifer Couzin-Frankel

PMID: 24357284
DOI: 10.1126/science.342.6165.1432

No abstract available

PubMed Disclaimer

Comment in

Cancer immunotherapy.
McNutt M. McNutt M. Science. 2013 Dec 20;342(6165):1417. doi: 10.1126/science.1249481. Science. 2013. PMID: 24357273 No abstract available.
Immunotherapy: it takes a village.
Pardoll D. Pardoll D. Science. 2014 Apr 11;344(6180):149. doi: 10.1126/science.344.6180.149-a. Science. 2014. PMID: 24723594 Free PMC article.

Similar articles

Cocktails for cancer with a measure of immunotherapy.
Ledford H. Ledford H. Nature. 2016 Apr 14;532(7598):162-4. doi: 10.1038/532162a. Nature. 2016. PMID: 27075078 No abstract available.
Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI, Rozati S, Goldinger SM, Widmer DS, Dummer R, Levesque MP. Raaijmakers MI, et al. Immunotherapy. 2013 Feb;5(2):169-82. doi: 10.2217/imt.12.162. Immunotherapy. 2013. PMID: 23413908 Review.
Cancer treatment: The killer within.
Ledford H. Ledford H. Nature. 2014 Apr 3;508(7494):24-6. doi: 10.1038/508024a. Nature. 2014. PMID: 24695297 No abstract available.
Therapeutic use of anti-CTLA-4 antibodies.
Blank CU, Enk A. Blank CU, et al. Int Immunol. 2015 Jan;27(1):3-10. doi: 10.1093/intimm/dxu076. Epub 2014 Jul 18. Int Immunol. 2015. PMID: 25038057 Review.
Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.
Demaria S, Dustin ML. Demaria S, et al. Immunotherapy. 2013 Feb;5(2):109-12. doi: 10.2217/imt.12.160. Immunotherapy. 2013. PMID: 23413900 No abstract available.

See all similar articles

Cited by

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.
Sharabi AB, Nirschl CJ, Kochel CM, Nirschl TR, Francica BJ, Velarde E, Deweese TL, Drake CG. Sharabi AB, et al. Cancer Immunol Res. 2015 Apr;3(4):345-55. doi: 10.1158/2326-6066.CIR-14-0196. Epub 2014 Dec 19. Cancer Immunol Res. 2015. PMID: 25527358 Free PMC article.
Novel molecular targets for urothelial carcinoma.
Faltas BM, Karir BS, Tagawa ST, Rosenberg JE. Faltas BM, et al. Expert Opin Ther Targets. 2015 Apr;19(4):515-25. doi: 10.1517/14728222.2014.987662. Epub 2015 Jan 30. Expert Opin Ther Targets. 2015. PMID: 25633079 Free PMC article. Review.
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach.
Mukherjee AG, Wanjari UR, Namachivayam A, Murali R, Prabakaran DS, Ganesan R, Renu K, Dey A, Vellingiri B, Ramanathan G, Doss C GP, Gopalakrishnan AV. Mukherjee AG, et al. Vaccines (Basel). 2022 Sep 7;10(9):1493. doi: 10.3390/vaccines10091493. Vaccines (Basel). 2022. PMID: 36146572 Free PMC article. Review.
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.
Yang P, Markowitz GJ, Wang XF. Yang P, et al. Natl Sci Rev. 2014 Jul 14;1(3):396-412. doi: 10.1093/nsr/nwu038. Natl Sci Rev. 2014. PMID: 25741453 Free PMC article.
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology.
Lontos K, Wang Y, Colbert M, Kumar A, Joshi S, Philbin M, Wang Y, Frisch A, Lohmueller J, Rivadeneira DB, Delgoffe GM. Lontos K, et al. Oncoimmunology. 2022 Oct 18;11(1):2131229. doi: 10.1080/2162402X.2022.2131229. eCollection 2022. Oncoimmunology. 2022. PMID: 36275862 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations